论文信息 - Phase II study of dasatinib in non-small cell lung cancer (NSCLC). - 字舞流文

Phase II study of dasatinib in non-small cell lung cancer (NSCLC).

J. Kurie | Y. Oh | B. Saigal | L. Hwang | Scott M. Lippman | Jeremy J. Erasmus | Faye M. Johnson | Xi Ming Tang | David J. Stewart | Hai T. Tran